Zobrazeno 1 - 10
of 41
pro vyhledávání: '"James W. Apriletti"'
Autor:
Phuong Nguyen, Paul Webb, James W. Apriletti, Marie Togashi, Ngoc Ha Nguyen, Igor Polikarpov, John D. Baxter, Thomas S. Scanlan, Suzana Telles da Cunha Lima
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Some nuclear receptor (NR) ligands promote dissociation of radiolabeled bound hormone from the buried ligand binding cavity (LBC) more rapidly than excess unlabeled hormone itself. This result was interpreted to mean that challenger ligands bind allo
Human Thyroid Receptor Forms Tetramers in Solution, Which Dissociate Into Dimers Upon Ligand Binding
Autor:
Luiz Alberto Simeoni, Sandra Martha Gomes Dias, Francisco de Assis Rocha Neves, Ana Carolina Migliorini Figueira, Maria A.M. Santos, Igor Polikarpov, James W. Apriletti, Paul Webb, Ralff C. J. Ribeiro, John D. Baxter
Publikováno v:
Cell Biochemistry and Biophysics. 44:453-462
Thyroid hormone nuclear receptors (TRs) bind to DNA and activate transcription as heterodimers with the retinoid X receptor (RXR) or as homodimers or monomers. RXR also binds to DNA and activates transcription as homodimers but can, in addition, self
Publikováno v:
Journal of Medicinal Chemistry. 46:3152-3161
The thyromimetic GC-1 shows a preference for binding the beta form of the thyroid hormone receptor (TR). GC-1 was designed as an analogue of the thyromimetic DIMIT, which has a lower affinity for TR and is not selective. GC-1 has a methylene group li
Autor:
Ben Sandler, John D. Baxter, Robert J. Fletterick, James W. Apriletti, Hoa Nguyen, Brian L. West, B. Russell Huber, Suzana T. Cunha Lima
Publikováno v:
Molecular Endocrinology. 17:643-652
Resistance to hormones is commonly due to mutations in genes encoding receptors. Resistance to thyroid hormone is due mostly to mutations of the beta-form of the human (h) thyroid hormone receptor (hTRbeta). We determined x-ray crystal structures of
Autor:
Hege Berghagen, James W. Apriletti, Kristin Krogsrud, Erlend Ragnhildstveit, Gunnar Thuestad, Fahri Saatcioglu
Publikováno v:
Journal of Biological Chemistry. 277:49517-49522
Nuclear receptors are ligand-modulated transcription factors that transduce the presence of lipophilic ligands into changes in gene expression. Nuclear receptor activity is regulated by ligand-induced interactions with coactivator or corepressor mole
Autor:
James W. Apriletti, Ngoc Ha Nguyen, Paul Webb, Suzana T. Cunha Lima, Thomas S. Scanlan, John D. Baxter
Publikováno v:
Journal of Medicinal Chemistry. 45:3310-3320
Recent efforts have focused on the design and synthesis of thyroid hormone (T(3)) antagonists as potential therapeutic agents and chemical probes to understand hormone-signaling pathways. We previously reported the development of novel first-generati
Autor:
Weijun Feng, Brian L. West, Paul Webb, Karin Mellstrom, James W. Apriletti, Thomas S. Scanlan, Ralff C. J. Ribeiro, John D. Baxter, Peter J. Kushner, Patrick Goede, Robert J. Fletterick, Richard L. Wagner, Stefan Nilsson
Publikováno v:
Endocrinology. 143:517-524
Antagonists have been developed for several nuclear receptors but not for others, including TRs. TR antagonists may have significant clinical utility for treating hormone excess states and other conditions. A structure derived "extension hypothesis"
Publikováno v:
Bioorganic & Medicinal Chemistry. 10:333-346
Compounds that selectively modulate thyroid hormone action by functioning as isoform-selective agonists or antagonists of the thyroid hormone receptors (TRs) might be useful for medical therapy. We have synthesized a high affinity TRbeta-selective ag
Autor:
B. Russell Huber, Suzana T. Cunha Lima, Andrew K. Shiau, Alexander E. Kelly, Robert J. Fletterick, Richard L. Wagner, Brian L. West, James W. Apriletti, Thomas S. Scanlan, John D. Baxter
Publikováno v:
Molecular Endocrinology. 15:398-410
Separate genes encode thyroid hormone receptor subtypes TRalpha (NR1A1) and TRbeta (NR1A2). Products from each of these contribute to hormone action, but the subtypes differ in tissue distribution and physiological response. Compounds that discrimina
Autor:
J. David Furlow, James W. Apriletti, Thomas S. Scanlan, Brian L. West, Robert J. Fletterick, Russ Huber, John D. Baxter, Wolfgang H. Dillmann, Paul Webb
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 76:31-42
Thyroid hormones have some actions that might be useful therapeutically, but others that are deleterious. Potential therapeutically useful actions include those to induce weight loss and lower plasma cholesterol levels. Potential deleterious actions